Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration Read More > December 2, 2016
The role of psychedelics in palliative care reconsidered: A case for psilocybin Read More > December 1, 2016
Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology Read More > December 1, 2016
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Read More > December 1, 2016
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Read More > December 1, 2016
Discriminative Stimulus Properties of MDMA: The Role of Serotonin and Dopamine Read More > December 1, 2016
Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future Read More > December 1, 2016
